Search concepts
|
Selected Filters
|
- 25,075 - 25,100 out of 25,991 results
Search results
-
Blood mitochondrial DNA biomarkers of midlife cognitive decline and adverse brain imaging changes – A longitudinal investigation in the CARDIA population‐based cohort study.
Hou, L., Zheng, Y., Gao, T. & Wang, J.
Columbia University, National Institute on Aging
7/15/20 → 4/30/25
Project: Research project
-
Room temperature high-power terahertz semiconductor laser with high-quality beam shape and stable spectral emission
5/15/22 → 4/30/25
Project: Research project
-
Electrostatics and Structure at Electrode:Electrolyte Interfaces from Nonlinear Optics
5/1/22 → 4/30/25
Project: Research project
-
RINGS: Robust and Resilient Wireless Networks using Next Generation Spectrum
5/1/22 → 4/30/25
Project: Research project
-
PSC subproject: Electrostatics and Structure at Electrode:Electrolyte Interfaces from Nonlinear Optics
5/1/22 → 4/30/25
Project: Research project
-
Collaborative Research: A Mechanical Atlas for Embryogenesis at Single-Cell Resolution
5/1/22 → 4/30/25
Project: Research project
-
Modeling the Glioblastoma Microenvironment to Uncover Progression Mechanisms and Therapeutic Targets
Brat, D. J., Horbinski, C. M., James, C. D. & Mukherjee, S.
5/1/20 → 4/30/25
Project: Research project
-
The American Lung Association (ALA) Lung Health Cohort
Carnethon, M. R., Kalhan, R., Yount, S., Bass, M. & Yount, S.
National Heart, Lung, and Blood Institute
6/15/19 → 4/30/25
Project: Research project
-
Prot #KRT-232-103: A Phase 1b/2, Open-Label Study Evaluating the Safety and Efficacy of KRT-232 in Patients with p53 Wild-Type (p53WT) Merkel Cell Carcinoma (MCC) Who Have Failed Anti-PD-1 or Anti-PD-L1 Immunotherapy, or in Combination with Avelumab in MC
Syneos Health, Inc., Kartos Therapeutics, Inc.
5/2/19 → 5/2/25
Project: Research project
-
DRUG 21516 - Open-label study of Androgen Receptor Inhibition with dArolutamide plus Androgen Deprivation Therapy (ADT) Versus ADT in men with Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm (ARASEC)
Parexel, Bayer HealthCare Pharmaceuticals, Inc.
5/4/22 → 5/4/25
Project: Research project
-
Prot #MK-3475-B21: A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curati
Gynecologic Oncology Group, Merck Sharp & Dohme LLC
5/11/22 → 5/11/25
Project: Research project
-
ACME III: A Search for the Electron Electric Dipole Moment
Yale University, Gordon E. and Betty I. Moore Foundation
1/10/20 → 5/15/25
Project: Research project
-
Prot #OCE-205-201: A Multi-Center, Randomized, Placebo-Controlled, Double-Blind, Adaptive Dose-Ranging Study to Assess Safety and Efficacy of Intravenous OCE-205 in Adults Diagnosed with Cirrhosis with Ascites who have Developed Hepatorenal Syndrome-Acute
CTI Clinical Trial and Consulting Services, Ocelot Bio, Inc.
5/20/22 → 5/20/25
Project: Research project
-
Prot#INCB 18424-305: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 3 (TRuE-AD3): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Childre
Premier Research International, LLC, Incyte Corporation
5/20/22 → 5/20/25
Project: Research project
-
MFMU PASC-PREG: Post-Acute Sequelae of SARS-CoV-2 Infection in Pregnant Patients and Their Offspring
University of Utah, National Heart, Lung, and Blood Institute
10/1/21 → 5/23/25
Project: Research project